Proteasome is major protein degradation machinery and plays essential roles in diverse 23 biological functions. Upon cytokine inductions, proteasome subunits β1, β2, and β5 are replaced 24 by β1i/LMP2, β2i/MECL-1, and β5i/LMP7, leading to the formation of immunoproteasome. 25
8 was the strongest, and Nef was modest ( Fig. 3D ). We further determined which residues 138 of Nef were essential for interacting with LMP7 by generating four site-directed mutations (Fig. 139 3E) . LMP7 strongly interacted with Nef and Nef -(105-108A), weakly interacted 140 with Nef (1-115)-(101-104A) , but not interacted with GFP, Nef -(109-112A), or Nef (1-141 115) -(113-115A) (Fig. 3F) , indicating that residues from 109 to 115 are crucial for the 142 interaction. The 7 residues were individually mutated to Alanine in Nef (Fig. 3G ). LMP7 143 strongly interacted with Nef , Nef(1-115)-(I109A), Nef(1-115)-(L110A), Nef -144 (D111A), Nef(1-115)-(W113A), and Nef(1-115)-(I114A), weakly interacted with Nef -145 (L112A), and barely interacted with Nef(1-115)-(Y115A) ( Fig. 3H ), suggesting that residues 12 146 and 15 are required for the interaction. Finally, a double residue mutant was generated to confirm 147 the role of L112 and Y115 in the interaction with LMP7 ( Fig. 3I ). LMP7 interacted with Nef (1-148 110) and Nef , weakly interacted with Nef(1-115)-(L112A), barely interacted with Nef(1-149 115)-(Y115A), but not interacted with Nef(1-115)-(L112A/Y115A) ( Fig. 3J ), demonstrating that 150 L112 and Y115 within the C2D domain of Nef are essential for the interaction. Several amino 151 acid residues within the C2D domain are essential for Nef oligomerization and interaction with 152 host proteins (28) (29) (30) . We demonstrate that residues L112 and Y115 within this domain are 153 required for interacting with LMP7. 154 155 Nef interacts with LMP7 to attenuate immunoproteasome formation. 156
The 20S core particle of constitutive proteasome (cProteasome) is a barrel-shaped structure 157 composed of 4 stacked rings: 2 outer rings contain α-subunits and act as binding sites for 158 regulatory complexes to access proteins into proteasome inner chamber, and 2 inner rings 159 contain β-subunits including β1, β2, and β5 active sites referred to "caspase-", "trypsin-", and 160 9 "chymotrypsin-like" (3). Upon cytokine stress such as interferon (IFN) induction, the three 161 catalytic subunits are replaced by distinct isoforms, β1i (LMP2), β2i (MECL-1), and β5i 162 (LMP7), leading to formation of immunoproteasome (iProteasome) (4, 5) . The biological effect 163 of the interaction between Nef and LMP7 was evaluated. LMP7 is a key factor for iProteasome 164 assembly ( Fig. 4A, B ) (31) (32) (33) . It is reasonable to speculate that Nef may affect iProteasome 165 formation by interaction with LMP7. To verify this, HeLa cells were treated with recombinant 166 human IFN- (rhIFN-). proLMP7 was expressed in the absence of rhIFN-, but not detected in 167 the presence of rhIFN-; in contrast, mLMP7 was not detected in the absence of rhIFN-, but 168 detected in the presence of rhIFN- ( Fig. 4C ); suggesting that IFN- induces LMP7 maturation. 169
Cell lysates, proteasomes, and iProteasomes were prepared from the cells transfected with Nef 170 and treated with rhIFN-. -actin was not detected in proteasomes or iProteasomes, but detected 171 in cell lysates ( Fig. 4D) , revealing that the proteasomes were successfully purified (34). 172
Endogenous LMP7 was not detected in proteasomes and cell lysates in the absence of rhIFN-, 173 but detected in iProteasomes and cell lysates in the presence of rhIFN- ( Fig. 4D ). In the 174 presence of rhIFN-, Nef was not detected in iProteasome, but detected in cell lysate ( Fig. 4D) , 175 suggesting that Nef is not associated with fully assembled iProteasome. Interestingly, LMP7 was 176 significantly attenuated by Nef in iProteasome, but relatively unaffected by Nef in cell lysate 177 ( Fig. 4D ). Moreover, LMP7 in iProteasomes was reduced by 80% in the presence of Nef ( Fig.  178 4E), suggesting that Nef attenuates the incorporation of LMP7 into iProteasome and thereby 179 down-regulates iProteasome formation. To further investigate whether myristoylation of Nef 180 would affect the formation of iProteasomes, the second amino acid glycine on Nef, which is 181 critical for the myristoylation of Nef (35), was mutated to alanine as Nef-G2A. Intriguingly, 182 LMP7 in iProteasomes was much decreased when Nef or Nef-G2A expressed, compared to 183 samples that empty vector transfected, when the cells were treated with rhIFN-, even the 184 expressions of LMP7 in both Nef and Nef-G2A transfected cells were higher than in empty 185 vector transfected cells in cell lysates (Fig. 4F ). Meanwhile, both of Nef and Nef-G2A were able 186 to reduce LMP7 in iProteasomes to 20% in the presence of rhIFN- ( Fig. 4G ), indicating that Nef 187 myristoylation may be not related to the formation of iProteasome. In order to study the effect of 188 the association of Nef and LMP7 on the assembly of iProteasomes, 3 Nef mutants were tested. 189 LMP7 was highly attenuated by Nef in iProteasomes, whereas was less attenuated by 190 both Nef(1-115)-(109-112A) and Nef(1-115)-(103-115A) ( Fig. 4H ). Meanwhile, LMP7 in 191 iProteasomes was reduced by about 90% in the presence of Nef, whereas 40% in the presence of 192
Nef(1-115)-(109-112A) and 20% in the presence of Nef(1-115)-(103-115A) ( Fig. 4I ), suggesting 193 that residues from 109 to 115 on Nef could be crucial for the inhibition of iProteasome formation. 194
The role of Nef in regulation of iProteasome was further determined using gradient 195 ultracentrifugation analyses. In the absence of Nef, proLMP7 was detected in the top fractions 1-196 2, while mLMP7 was distributed in the bottom fractions 6-7 ( Fig. 4J ). In the presence of Nef, 197 proLMP7 was detected in the top fractions 1-3, mLMP7 was presence in the bottom fractions 5-198 8, and Nef was distributed in the top fractions 6-7 ( Fig. 4K ). These results further suggest that 199
Nef is not associated with assembled iProteasome, but instead Nef interacts with LMP7 to 200 prevent incorporation of LMP7 into iProteasome. Nef also exhibited the ability to inhibit LMP7 201 incorporated into iProteasome ( Fig. 4L ), which is similar as the data in Fig 4D. It was reported 202 that critical steps of iProteasome formation occur on the ER membrane (36). We showed that 203 both Nef and LMP7 were distributed mostly on the ER membrane in the cytosol, when they were 204 expressed alone. While a large proportion of Nef and LMP7 also co-localized and distributed on 205 the ER membrane when they were expressed together ( Fig. 4M, N) . Interestingly, Nef and 206 11 mLMP7 co-localized and distributed mostly on the ER membrane in the cytosol too. However, 207
Nef did not co-localized with proD, and Nef but not proD localized on the ER membrane in the 208 cytosol, suggesting that the interaction between Nef and LMP7 plays an important role on the co-209 localization on the ER membrane ( Fig. 4M, N) . Thus, we demonstrate that a relatively large 210 amount of Nef interacts with LMP7 on the ER membrane to prevent LMP7 from incorporation 211 into iProteasome, and thereby attenuate iProteasome formation at early stage. 212 213
Nef attenuates immunoproteasome protein degradation activity and MHC-I antigen 214
presentation function. 215
The central task of iProteasome is to degrade ubiquitylated proteins that are executed ubiquitin 216 proteasome system (UPS) ( Fig. 5A) (37, 38) . The effects of Nef on ubiquitylated protein 217 degradation function of iProteasome were determined. Cells were transfected with pNef and 218 treated with rhIFN-. Ubiquitinated proteins were induced by rhIFN- and further enhanced by 219 Nef (Fig. 5B , C). Cells were then infected with HIV-1 (pNL4-3) or Nef-deficient HIV-1 (pNL4-220 3dNef) and treated with rhIFN-. Ubiquitinated proteins were induced by rhIFN-, further 221 enhanced by pNL4-3, but not affected by pNL4-3dNef ( Fig. 5D , E). The results demonstrate that 222 Nef protects protein ubiquitination by attenuating iProteasome protein degrading function. 223
Immunoproteasomes process cellular proteins into peptides that are loaded onto MHC-I to 224 communicate intracellular protein composition to immune system (39, 40) . Deletion of LMP7 225 reduces MHC-I cell surface expression (41). Here, the effects of Nef on regulating MHC-I 226 trafficking and antigen presentation were determined by using an siRNA, which is specifically 227 targeting human LMP7 mRNA. In CD4+ Jurkat T cells, the expression of LMP7 was reduced by 228 50% in the presence of siR-hLMP7, compared to in the presence of siR-hCtrl ( Fig. 5F , G). CD4+ 229 Jurkat T cells were transfected with siR-hLMP7 or siR-hCtrl, which were negative controls, 230 while cells stained with IgG isotype antibody were served as MHC-I negative controls (Fig. 5H) . 231
Additionally, the relative mean fluorescence intensity (MFI) was significantly reduced to 60% by 232
Nef in the presence of siR-hCtrl ( Fig. 5I ), indicating that Nef attenuates MHC-I cell surface 233 expression. Then the relative MFI was significantly up-regulated to 70% by Nef in the presence 234 of siR-hLMP7 ( Fig. 5I ), suggesting that LMP7 is involved in Nef-mediated attenuation of MHC-235 I cell surface expression. Interestingly, the relative MFI was reduced to 90% in the presence of 236 siR-hLMP7 ( Fig. 5I ), revealing that MHC-I trafficking is attenuated by siR-hLMP7. Therefore, 237
the results demonstrate that MHC-I trafficking is repressed by Nef and attenuated by siR-hLMP7, 238
and thus LMP7 is involved in Nef-mediated attenuation of MHC-I trafficking. 239 240
Nef inhibits MHC-I antigen presentation pathway by hijacking LMP7. 241
The iProteasome mediates immune responses by efficiently generating peptides for antigen 242 presentation of MHC-I, which is an efficient surveillance system that present antigens when 243 hosts are invaded by pathogens. The beginning step in the MHC-I signaling pathway is 244 processing the antigenic proteins into peptides and loading them onto peptide loading complex 245 (PLC), in which iProteasomes play a vital role. MHC-I molecules present a diverse array of 246 antigenic peptides (immunopeptidome) to circulating TCLs. Here, the biological effect of Nef on 247 MHC-I function was determined using an antigen-presenting cell (APC) system (42, 43) . 248
Ovalbumin (OVA) specific antigen presentation assay was carried out, in which mouse 249 leukaemic monocyte macrophages (RAW264.7) were transfected with mouse siRNA siR-250 mLMP7 or control siRNA siR-mCtrl (Fig. 6A ). The expression of LMP7 was reduced to 52% in 251 the presence of siR-mLMP7, compared to in the presence of siR-mCtrl ( Fig. 6B ). Then 252 13 RAW264.7 cells were transfected with pNef-Flag or empty vector and incubated with OVA, and 253 the cells were co-cultured with mouse CD8 + T B3Z cells that recognize OVA-generated peptide 254 and promote IL-2 secretion, an indicator of antigen presentation (Fig. 6C ). Secreted IL-2 protein 255 was induced by OVA in the presence of siR-mCtrl (from 2 pg/ml to 99 pg/ml), or in the presence 256 of siR-mLMP7 (from 3 pg/ml to 81 pg/ml). However induction of IL-2 was inhibited by Nef in 257 the presence of siR-mCtrl (from 99 pg/ml to 51 pg/ml), while this inhibition by Nef was 258 significantly impaired in the presence of siR-mLMP7 (from 51 pg/ml to 65 pg/ml) ( Fig. 6D, E) , 259 suggesting that Nef represses MHC-I antigen presentation and LMP7 is involved in such 260
repression. Taken together, this study reveals a distinct mechanism by which HIV-1 Nef interacts 261 with LMP7 to promote immune evasion by suppressing iProteasome formation and protein 262 degradation function, and repressing MHC-I trafficking and antigen-presentation activity (Fig. 7) . inflammatory effect in inflammatory models (45, 46) . In addition to its function in immune 272 responses, LMP7 plays a role in management of protein homeostasis under oxidative stress and 273 LMP7-deficiency leads to intracellular protein aggregations and autoimmune encephalomyelitis 274 (33, 47) . 275
Formation of iProteasome is a multi-step, delicate, and strictly regulated process, including 276 the assembly of immature 16S precursor, the cleavage of pro-sequences from subunits, and the 277 formation of mature 20S core particle (32, 33) . The formation of  ring is on top of assembled  278 ring, and the adding of  subunits follows a highly strict order (44). Proteasome 20S core particle 279 contains three active subunits with caspase-, trypsin-, and chymotrypsin-like activities that are 280 replaced by related proteases LMP2, MECL1, and LMP7 in iProteasome (48). This exchange of 281 proteolytic activities makes iProteasomes more efficient at generation of peptides for antigen 282 presentation (49). This study demonstrates that Nef interacts with LMP7 on the ER membrane 283 and attenuates incorporation of LMP7 into iProteasome and thereby down-regulates iProteasome 284 formation. Interestingly, both proLMP7-GFP and mLMP7-GFP were able to pull down more Nef 285 than proLMP7 (Fig. 2D) , although mLMP7 pulled down less Nef than proLMP7 (Fig. 2B) , 286
which may raise a hypothesis that when GFP fused to either full length or mature domain of 287 15 LMP7, it was able to stabilize their structures and enhance their bindings with Nef. Moreover, 288
Nef represses iProteasome protein degradation function upon IFN stimulation, suggesting that 289 iProteasomes is related to cellular ubiquitination under oxidative stress. 290
The iProteasome mediates immune responses by efficiently generating peptides for antigen 291 presentation of MHC-I, which is an efficient surveillance system that present antigens when 292 hosts are invaded by pathogens (50). The beginning step in the MHC-I signaling pathway is 293 processing the antigenic proteins into peptides and loading them onto PLCs, in which 294 iProteasomes play a vital role (51) . MHC-I molecules present a diverse array of antigenic 295 peptides (immunopeptidome) to circulating TCLs (52). Interestingly, Nef represses the 296 trafficking and antigen presentation activities of MHC-I. 297
Nef is able to counteract the host immunity (23-27). This study reveals a distinct 298 mechanism by which HIV-1 promotes immune evasion by attenuating the functions of 299 iProteasome and MHC-I through Nef. Nef interacts with LMP7 on the ER membrane and 300 attenuates incorporation of LMP7 into iProteasome to down-regulate the formation and protein 301 degradation function of iProteasome, leading to repress the trafficking and antigen presentation 302 Wild type HIV-1 plasmid (pNL4-3) was obtained from NIH (Rockville, MD, USA) and Nef-326 deficient HIV-1 plasmid (pNL4-3dNef) was generated from pNL4-3. pNL4-3 and pNL4-3dNef 327 were transfected into HEK293T cells using polyethylenimine (PEI) transfection reagents 328 (Polysciences, PA, USA). At 48 h post-transfection, the cell culture media were collected and the 329 cell debris was removed by centrifugations. Virus titers were measured using p24 enzyme-linked 330 immunosorbent assays (ELISA) (RD Systems, MN, USA). CD4 + Jurkat T cells were incubated 331 with NL4-3 or NL4-3dNef viruses at MOI: 10 ng p24 per 10 6 cells for 2 h. The cells were 332 washed and replaced with fresh culture media. The cells or supernatants were collected at 333 indicated time for further analyses. 334 335
Stable cell lines 336
Flag tagged Nef gene was constructed into pLenti vector (Invitrogen). pLenti-Nef plasmids or 337 pLenti empty vectors were co-transfected with pLP1, pLP2, and pLP/VSVG plasmids 338 (Invitrogen) into HEK293T cells by using PEI transfection reagents. The cell supernatants 339 containing Lentiviruses were collected after 2 days of transfections. CD4 + Jurkat T cells were 340 infected with Lentiviruses containing Nef or empty vector respectively. Stable Nef expressing 341 cells were selected with 2.5 µg/ml puromycin. 342 343
Protein polyubiquitylation. 344
HeLa cells were incubated with 100 U/ml rhIFN- after 1 day of transfection with Nef plasmids 345 or empty vectors. Alternatively, CD4 + Jurkat cells were incubated with 100 U/ml rhIFN- after 2 346 h of infections with wild type NL4-3 or Nef deficient NL4-3dNef viruses. The cells were 347 harvested and lysed for western blots at indicated time. HeLa cells were seeded in 15 mm glass bottom dishes (Nest Scientific, NJ, USA) 1 day before 365 transfections. 1 µg plasmids were transfected for each dish. Cells were washed 3 times with 366 phosphate buffer saline (PBS) and fixed with 1% formaldehyde in PBS for 30 min at 24 h post 367 transfections. After 3 times washes with PBS, cells were permeabilized in buffer (PBS 368 containing 1% bovine serum albumin and 0.1% saponin) for 30 min, and then incubated with 369 anti-HA or anti-Flag (Sigma-Aldrich, MO, USA) for 1 h. Cells were washed 3 times with 370 permeabilization buffer, and then incubated with secondary antibodies for 1 h. After 3 times 371 washes with PBS, cells were stained with endoplasmic reticulum (ER)-Tracker Red dyes 372 19 (Invitrogen) for 30 min. Then cells were washes 3 times in PBS and viewed by using FluoView 373 FV1000 (Olympus, Tokyo, Japan) confocal microscope. 374 375
Recombinant protein expression and purification. 376
Nef and LMP7 genes were cloned into pGEX-6P-1 (GE, Boston, MA, USA) and pET-28a 377 plasmids respectively (Novagen, Madison, WI, USA). pGEX-6P-1 empty plasmid and pEGX-378 6P-1-Nef plasmid were respectively transformed into BL21 (DE3) competent cells (TransGen, 379 Beijing, China). Alternatively, pET-28a-LMP7 plasmids were transformed into BL21 (DE3) 380 competent cells (TransGen). The cells were grown in LB buffer with 0.1mM IPTG at 30°C for 381 16 h, then harvested by centrifugation at 3,000 g for 10 min. The cell pellets were re-suspended 382 in PBS, then frozen and thawed for 3 times, and sonicated for 10 min (pulse on for 5 s and pulse 383 off for 5 s) on ice. The supernatants were collected by centrifugation at 12,000 rpm for 10 min, 384 then the proteins were purified by using NGC Scout10 (Bio-Rad, Hercules, CA, USA) according 385 to manufacturer's protocol. 
Biolayer interferometry (BLI) assay. 396
Purified LMP7 proteins from bacteria were linked with NHS-LC-LC-biotin (Thermo Fisher) as a 397 1:3 molar ratio at room temperature for 1 h. Proteins were clarified through Zeba spin desalting 398 columns (Thermo Fisher) to remove un-reacted biotin. The Streptavidin biosensors (ForteBio, 399 Menlo Park, CA, USA) were sequentially dipped into wells of black 96-well plates (Greiner, 400 Kremsmünster, Austria) containing PBS, LMP7, PBS, GST or Nef-GST, and PBS. All the 401 association and dissociation curves were fitted 1:1 binding model. 402
403

Proteasome purification. 404
HeLa cells were seeded in 10-cm dishes 1 day before transfections. 10 µg Nef-HA or empty 405 vector plasmids were transfected into the cells at 50-80% confluence for each dish by mixing 406 with 20 µl PEI transfection reagents. After 24 h post transfection, the cells were treated with 100 407 U/ml IFN- (Peprotech, Rocky Hill, NJ, USA) for 24 h. Cells were trypsinized after washed with 408 pre-chilled PBS, then lysed in 1 ml buffer A (50 mM Tris-HCl, pH7.5, 250 mM sucrose, 150 409 mM NaCl) by 3 times of freeze and thaw for each dish. Cell lysates were pre-clarified by 410 centrifugation at 1,000 g for 5 min at 4°C. The supernatant was collected and clarified again at 411 10,000 g for 20 min at 4°C. A 20 µl supernatant aliquot of each sample was saved and stored at 412
4°C until further analysis. The rest of the samples were spun in buffer A at 100,000 g for 1 h at 413 16°C. After discarding the pellets, the supernatant was spun at 100,000 g for 5 h, at 16°C. well. After 24 h transfections of siRNA, cells were treated with 100 U/ml rhIFN- for 24 h. The 442 cells were collected and incubated with block reagents (1% bovine serum albumin, BSA in PBS) 443 (Sigma-Aldrich) for 30 min after fixing with 1% formaldehyde in PBS for 10 min. The cells 444
were incubated with W6/32 APC or isotype control antibodies for 1 h. After filtering with 445 membranes, the cells were analyzed by using Cytoflex (Beckman, Brea, CA, USA), and 50,000 446 events were collected for each sample. 447 448 Antigen presentation assay. 449 RAW264.7 cells were seeded in 24-well plates. After cells attached to the plates, 20 ng purified 450 GST or GST-Nef proteins purified from bacteria were added into the cell media for each well at 451 50% cell confluence for 15 h. After 3 times washes with PBS, cell media was replaced by Opti-452 MEM I reduced serum medium (Thermo Fisher) with 10 mg/ml egg white ovalbumin (OVA) 453 (Sangon Biotech, Shanghai, China) for 6 h. After 3 times washes with PBS, the cells were co-454 cultured with B3Z cells for 24 h. The cell culture media was collected and spun at 12,000 rpm 455 for 10 min to discard the cell debris then frozen at -80°C until further measurements. ELISA was 456 performed to measure IL-2 concentration of the thawed samples by using mouse IL-2 ELISA set 457 (BD Biosciences, Franklin Lakes, NJ, USA) according to manufacturer's instructions. 458 459 Yeast two-hybrid assay. 460
Nef and LMP7 genes were constructed into pGBKT7 and pGADT7 vectors (Clontech), 461 respectively. pGBKT7-Nef and pGADT7-LMP7 plasmids were transformed into Y2HGold and 462 Y187 yeast strains to grow at 30°C for 3 days. Y2HGold and Y187 yeasts (Clontech) were 463 picked and mix together to grow in YPDA broth at 200 rpm, 30°C for overnight. The mated 464 23 culture was plated on DDO (-Leu/-Trp) agar plates to grow at 30°C for 3 days. Colonies were 465 picked and streaked on QDO (-Ade/-His/-Leu/-Trp), and X--Gal agar plates to grow at 30°C for 466 3 days. 467 468
Statistics. 469
All experiments were repeated at least three times with similar results. All results were expressed 470 as the mean ± the standard deviation (SD). Statistical analysis was carried out using the two-471 tailed t-test (GraphPad Prism5). The date difference was considered statistically significant when 472 P ≤0.05 (*), P ≤0.01 (**), P ≤0.001 (***); NS, not significant. 473
